Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Grünenthal Group
Pharma
Eisai, BeiGene, Shionogi—Fierce Pharma Asia
Eisai fields lecanemab safety questions in its full data release. BeiGene's Brukinsa betas Imbruvica in CLL. Shionogi's COVID drug snags first nod.
Angus Liu
Dec 2, 2022 10:00am
Kyowa Kirin offloads mature drugs to Grünenthal in Europe
Nov 28, 2022 11:00am
Grünenthal buys up Nebido from Bayer for $500 million
Jul 14, 2022 9:44am
AZ hands European Crestor rights to old customer Grünenthal
Dec 1, 2020 10:50am
AstraZeneca's rummage sale continues with second deal in a week
Nov 6, 2018 10:08am